An FDA committee will meet today to discuss possibly granting the Johnson & Johnson single-dose COVID-19 vaccine emergency use authorization.
KDKA's Lindsay Ward has more on the new vaccine.
An FDA committee will meet today to discuss possibly granting the Johnson & Johnson single-dose COVID-19 vaccine emergency use authorization.
KDKA's Lindsay Ward has more on the new vaccine.
On April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson's..